Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women.

The results of a two recent, three year, randomized, placebo-controlled, prospective, indepent studies, were published in the journal, Menopause. The study authors concluded, "This analysis, from a large cohort of postemenopausal women, demonstrated for the first time that a pharmacological intervention for OA (osteoarthritis) has a disease-modifying effect in this particular population, the most frequently affected by knee OA.


References:
Bruyere O, Pavelka K, Royati LC, Deroisy R, Olejarova M, Gatterova J, Giacovelli G, Reginster JY. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3 year studies. Menopause. 2004 Mar-Apr; 11(2):138-43.

Glucosamine use in pregnancy: an evaluation of pregnancy outcome.

 

Is Glucosamine safe to use in pregnancy?

From a recent study published in the Journal of Womens Health, there's limited information to answer this question.

"CONCLUSIONS: These limited data suggest no increased risk for major malformations or other adverse fetal effects following the use of GLS during pregnancy."

Reference:
Sivojelezova A, Koren G, Einarson A. Glucosamine use in pregnancy: an evaluation of pregnancy outcome. J Womens Health (Larchmt). 2007 Apr